Search research articles
Contact Us
Filters
Showing results (441-450 of 487) with videos related to
Page
of 49
Sort By:
JAAD International
|
November 17, 2022
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types
Angela L Bosma, Wouter Ouwerkerk, Madeline J Heidema, et al.
Skin Health and Disease
|
June 30, 2025
A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
Elizaveta Gribaleva, Niels Steen Krogh, David Prieto-Merino, et al.
The Journal of Allergy and Clinical Immunology
|
March 8, 2011
Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy
Sara J Brown, Yuka Asai, Heather J Cordell, et al.
The British Journal of Dermatology
|
July 24, 2024
A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR register
Helen Alexander, Rayka Malek, David Prieto-Merino, et al.
Nature Genetics
|
August 27, 2013
Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting
Liat Samuelov, Ofer Sarig, Robert M Harmon, et al.
The Journal of Investigative Dermatology
|
August 14, 2016
Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) Mutations
Julie Soblet, Jaakko Kangas, Marjut Nätynki, et al.
The Journal of Allergy and Clinical Immunology
|
September 9, 2008
Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk
Stephan Weidinger, Hansjörg Baurecht, Stefan Wagenpfeil, et al.
The British Journal of Dermatology
|
September 18, 2023
Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial
Carsten Flohr, Anna Rosala-Hallas, Ashley P Jones, et al.
The Journal of Investigative Dermatology
|
July 9, 2016
AP1S3 Mutations Cause Skin Autoinflammation by Disrupting Keratinocyte Autophagy and Up-Regulating IL-36 Production
Satveer K Mahil, Sophie Twelves, Katalin Farkas, et al.
The Journal of Allergy and Clinical Immunology
|
January 15, 2019
Report from the National Institute of Allergy and Infectious Diseases workshop on "Atopic dermatitis and the atopic march: Mechanisms and interventions"
Wendy F Davidson, Donald Y M Leung, Lisa A Beck, et al.
Page
of 49
Search research articles
Search
Showing results (441-450 of 487) with videos related to
Sort By:
Page
of 49
JAAD International
|
November 17, 2022
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types
Angela L Bosma, Wouter Ouwerkerk, Madeline J Heidema, et al.
Skin Health and Disease
|
June 30, 2025
A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
Elizaveta Gribaleva, Niels Steen Krogh, David Prieto-Merino, et al.
The Journal of Allergy and Clinical Immunology
|
March 8, 2011
Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy
Sara J Brown, Yuka Asai, Heather J Cordell, et al.
The British Journal of Dermatology
|
July 24, 2024
A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR register
Helen Alexander, Rayka Malek, David Prieto-Merino, et al.
Nature Genetics
|
August 27, 2013
Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting
Liat Samuelov, Ofer Sarig, Robert M Harmon, et al.
The Journal of Investigative Dermatology
|
August 14, 2016
Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) Mutations
Julie Soblet, Jaakko Kangas, Marjut Nätynki, et al.
The Journal of Allergy and Clinical Immunology
|
September 9, 2008
Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk
Stephan Weidinger, Hansjörg Baurecht, Stefan Wagenpfeil, et al.
The British Journal of Dermatology
|
September 18, 2023
Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial
Carsten Flohr, Anna Rosala-Hallas, Ashley P Jones, et al.
The Journal of Investigative Dermatology
|
July 9, 2016
AP1S3 Mutations Cause Skin Autoinflammation by Disrupting Keratinocyte Autophagy and Up-Regulating IL-36 Production
Satveer K Mahil, Sophie Twelves, Katalin Farkas, et al.
The Journal of Allergy and Clinical Immunology
|
January 15, 2019
Report from the National Institute of Allergy and Infectious Diseases workshop on "Atopic dermatitis and the atopic march: Mechanisms and interventions"
Wendy F Davidson, Donald Y M Leung, Lisa A Beck, et al.
Page
of 49